Kantonsspital Lucerne Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01255722
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Kantonsspital Lucerne- Switzerland | Kantonsspital Luzern, Augenklinik, CH-6000 Luzern 16, Switzerland

Active Ingredients

Drugs in Phase 4 Trials (3)

iobitridol (Xenetix) (1 trial)

Iomeprol (1 trial)

iopromide (ultravist) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3